Establishment Labs Holdings Inc. Overview
Pro stress-test →Establishment Labs is a global medical technology company focused on improving patient safety and aesthetic outcomes in the breast aesthetics and reconstruction market by designing, developing, manufacturing, and marketing silicone gel-filled breast implants, branded as Motiva Implants®, which form the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA-compliant state-of-the-art facilities in Costa Rica and are currently approved for commercial distribution in over 70 countries.
Strategic Profile
Pro stress-test →The company's strategic focus has expanded to minimally invasive platforms, with products including Mia Femtech® and the recently launched Preservé™, which allow less invasive breast surgery for aesthetic augmentation and reconstruction. As of November 2025, Establishment Labs has a market cap of $1.88B with trailing 12-month revenue of $191M, positioning it as a specialized leader in the femtech medical device space.
Competitive Landscape
Pro stress-test →Establishment Labs competes in the aesthetic medical device space with companies like Integra LifeSciences Holding and other breast implant manufacturers. The company differentiates through proprietary minimally invasive technologies, international regulatory approvals in 70+ countries, and advanced safety features in its Motiva product line.
Industry Context
Establishment Labs Holdings Inc. operates in Medical Device Manufacturing - Aesthetic and Reconstructive Surgery.
Key facts
Founded: 2004 · Headquarters: Alajuela, Costa Rica · Employees: 938-1023 · Revenue: $191M · Market cap: $1.88B